Cytostatic response of HepG2 to 0.57 MHz electric currents mediated by changes in cell cycle control proteins

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1399-1405

  Hernández Bule, María Luisa ^a   Cid, María Antonia ^a   Trillo, María Ángeles ^a   Leal, Jocelyne ^a   Úbeda, Alejandro ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cell cycle; Cyclins; HepG2; RF currents

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ARTICLE; CAPACITIVE RESISTIVE ELECTRIC TRANSFER THERAPY; CELL ACTIVATION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CYTOSTASIS; ELECTRIC CURRENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTRIC STIMULATION THERAPY; ELECTRICITY; FLUORESCENCE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 78649926518     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000791     Document Type: Article

References (45)

1. Uozumi H, Baba Y, Yasunaga T and Takahashi M: Clinical evaluation of combined hyperthermia and radiation therapy for radioresistant superficial malignant tumors. Radiat Med 5: 121-130, 1987.
2. Loh J, Seong JS, Suh CO, Kim GE, Chu SS, Park KR, Lee CG, Kim BS and Seel DJ: Cooperative clinical studies of hyperthermia using a capacitive type heating device GHT-RF8 (Greenytherm). Yonsei Med J 30: 72-80, 1989.
3. Sakamoto T, Katoh H, Shimizu T, Yamashita I, Takemori S, Tazawa K and Fujimaki M: Clinical results of treatment of advanced carcinoma with hyperthermia in combination with chemoradiotherapy. Chest 112: 1487-1493, 1997. (Pubitemid 28007752)
4. Hager ED, Dziambor H, Hohmann D, Salenbeck D, Stephan M and Popa C: Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer. Anticancer Res 19: 3403-3408, 1999. (Pubitemid 30000195)
5. Matsui Y, Nakagana A, Kamiyama Y, Yamamoto K, Kubo N and Nakase Y: Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 20: 14-20, 2000.
6. Ohguri T, Imada H, Yahara K, Kakeda S, Tomimatsu A, Kato F, Nomoto S, Terashima H and Korogi Y: Effect of 8-MHz radiofrequency-capacitive regional hyperthermia with strong superficial cooling for unresectable or recurrent colorectal cancer. Int J Hyperthermia 20: 465-475, 2004.
7. Kamisawa T, Tu Y, Egawa N, Karasawa K, Matsuda T, Tsuruta K and Okamoto A: Thermo-chemo-radiotherapy for advanced bile duct carcinoma. World J Gastroenterol 1: 4206-4209, 2005. (Pubitemid 41086872)
8. Hernández-Bule ML, Trillo MA, Cid MA, Leal J and Úbeda A: In vitro exposure to 0.57MHz electric currents exerts cytostatic effects in HepG2 human hepatocarcinoma cells. Int J Oncol 30: 583-592, 2007.
9. Ley A, Cladellas M and Colet P: Transferencia Eléctrica Capacitiva (TEC). Técnica no invasiva de hipertermia profunda en el tratamiento de los gliomas cerebrales. Resultados preliminares. Neurocir Soc Luso Esp Neurocir 3: 118-123, 1992.
10. Ley A, Ariza A and Rosell R: Tratamiento quirúrgico de los gliomas malignos. Hipertermia. In: Tumores del Sistema Nervioso Central. Doyma (eds.), Barcelona, pp64-66, 1993.
11. Takashima S and Schwan HP: Alignment of microscopic particles in electric fields and its biological implications. Biophys J 47: 513-518, 1985.
12. Zimmermann U, Vienken J and Pilwat G: Rotation of cells in an alternating electric field: the occurrence of a resonance frequency. Z Naturforsch C 36: 173-177, 1981.
13. Holzapfel C, Vienken J and Zimmermann U: Rotation of cells in an alternating electric field: theory an experimental proof. J Membr Biol 67: 13-26, 1982.
14. Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, Wasserman Y, Schatzberger R and Palti Y: Disruption of cancer cell replication by alternating electric fields. Cancer Res 64: 3288-3295, 2004.
15. Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Schneiderman R, Wasserman Y, Salzberg M, Ryffel B, Goldsher D, Dekel E and Palti Y: Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci USA 107: 10152-10157, 2007.
16. Salzberg M, Kirson ED, Palti Y and Rochlitz C: A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Onkologie 31: 362-365, 2008.
17. Hernández-Bule ML, Trillo MA, Bazán E, Martínez- Pascual MA, Leal J and Úbeda A: Niveles atérmicos de corrientes eléctricas usadas en terapia por transferencia eléctrica capacitiva inducen efectos citotóxicos parciales en cultivos de neuroblastoma humano. Neurocir Soc Luso Esp Neurocir 15: 366-371, 2004.
18. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, De Caprio JA and Ewen ME: Ras signalling linked to the cell-cycle machinery by retinoblastoma protein. Nature 386: 177-181, 1997. (Pubitemid 27131445)
19. Cheng K and Goldman RJ: Electric fields and proliferation in a dermal wound model: cell cycle kinetics. Bioelectromagnetics 19: 68-74, 1998. (Pubitemid 128474900)
20. Kato J: Induction of S phase by G1 regulatory factors. Front Biosci 4: D787-D792, 1999.
21. Huynh H, Do PT, Nguyen TH, Chow P, Tan PH, Quach TH, Van T, Soo KC and Tran E: Extracellular signal-regulated kinase induces cyclin D1 and Cdk2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma. Int J Oncol 25: 1839-1847, 2004.
22. Villanueva J, Yung Y, Ealker Jl and Assoian RK: ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol Biol Cell 18: 1457-1463, 2007. (Pubitemid 46626640)
23. Pines J and Hunter T: Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 115: 1-17, 1991. (Pubitemid 21909889)
24. Gillett CE and Barnes DM: Demystified cell cycle. Mol Pathol 51: 310-316, 1998.
25. Barnes DM and Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1-15, 1998.
26. Wang E, Yin Y, Zhao M, Forrester JV and McCaig CD: Physiological electric fields control the G1/S phase cell cycle checkpoint to inhibit endothelial cell proliferation. FASEB J 17: 458-460, 2003.
27. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM and Weinstein IB: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196: 1010-1016, 1993.
28. Lee J, Choi H, Nguyen P, Kim J, Lee SJ and Trepel JB: Cyclic AMP induces inhibition of cyclin A expression and growth arrest in human hepatoma cells. Biochim Biophys Acta 1449: 261-268, 1999.
29. Chao Y, Shih YL, Chen HJ, Lee SD and Huang TS: Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells. Cancer Lett 13: 1-6, 1999.
30. Atadja P, Wong H, Veillete C and Riabowol K: Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblast. Exp Cell Res 217: 205-216, 1995.
31. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R and McCubrey JA: Regulation of cell cycle progression and apoptosis by Ras/Raf/MEK/ERK pathway. Int J Oncol 22: 469-480, 2003.
32. Murphy LO and Blenis J: MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31: 268-275, 2006. (Pubitemid 43674354)
33. Shaul YD and Seger R: The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773: 1213-1226, 2007.
34. 2+, c-AMP-responsive element binding proteins and mitogen-activated protein kinase signalling. J Neurosci 17: 7252-7266, 1997.
35. Wang E, Zhao M, Forrester JV and McCaig CD: Electric fields and MAP kinase signalling can regulate early wound healing in lens epithelium. Invest Ophthalmol Vis Sci 44: 244-249, 2003.
36. Borel F, Lacroix FB and Margolis RL: Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phases stasis. J Cell Sci 115: 2829-2838, 2002.
37. Hurley PJ, Wilsker D and Bunz F: Human cancer cells require ATR for cell cycle progression following exposure to ionising radiation. Oncogene 26: 2535-2542, 2007.
38. Coqueret O: New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70, 2003.
39. kip1, inhibits growth and enhances apoptosis. Cell Growth Differ 7: 699-710, 1996.
40. KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 18: 1139-1148, 1997.
41. Zhou Q, He Q and Liang LJ: Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol 9: 2450-2454, 2003.
42. Calabrese EJ and Baldwin LA: Defining hormesis. Hum Exp Toxicol 21: 91-97, 2002.
43. Malumbres M, Pevarello P, Barbacid M and Bischoff JR: CDK inhibitors in cancer therapy: what is next? Trends Pharmacol Sci 29: 16-21, 2007.
44. Senderowicz AM: Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasm. Cancer Chemother Pharmacol 52: S61-S73, 2003.
45. Tian Z, Shen J, Moseman AP, Yang Q, Yang J, Xiao P, Wu E and Kohane IS: Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells. Int J Cancer 122: 31-38, 2008. (Pubitemid 350209975)